SCHEMBL5520510

SCHEMBL5520510

C=CCCCC(=O)N1C(=O)OC[C@H]1C(C)C

nearest known ligand 0.51

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
IL6ST P40189 5/20 0.51
STAT3 P40763 1/20 0.50
PIK3CD O00329 1/20 0.42
FAAH O00519 9/20 0.42
MGLL Q99685 4/20 0.42
NAAA Q02083 3/20 0.40
PLA2G1B P04054 1/20 0.33
PLA2G2A P14555 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8030492 0.96 IL6ST (0.52) IL6STSTAT3PIK3CDFAAHMGLL
SCHEMBL8030490 0.96 IL6ST (0.52) IL6STSTAT3PIK3CDFAAHMGLL
SCHEMBL7428524 0.92 IL6ST (0.50) IL6STSTAT3PIK3CDFAAHMGLL
SCHEMBL2882140 0.92 IL6ST (0.50) IL6STSTAT3PIK3CDFAAHMGLL
SCHEMBL2882143 0.92 IL6ST (0.50) IL6STSTAT3PIK3CDFAAHMGLL
SCHEMBL15619064 0.85 IL6ST (0.64) IL6STSTAT3PIK3CDFAAHNAAA
SCHEMBL3838379 0.85 IL6ST (0.64) IL6STSTAT3PIK3CDFAAHNAAA
SCHEMBL5598050 0.84 IL6ST (0.56) IL6STSTAT3PIK3CDFAAHNAAA
SCHEMBL2073113 0.84 IL6ST (0.56) IL6STSTAT3PIK3CDFAAHNAAA
SCHEMBL11936832 0.83 IL6ST (0.65) IL6STSTAT3PIK3CDFAAHNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798181-A (R) -4-isopropyl-3- ((R) -2-methyl-5-hexenoyl) oxazolidin-2-one and application thereof in synthesis of inchworm sex pheromone component of Western iron yew 山东省农业科学院 2025-04-11 CN claimed
CN-119798181-A (R) -4-isopropyl-3- ((R) -2-methyl-5-hexenoyl) oxazolidin-2-one and application thereof in synthesis of inchworm sex pheromone component of Western iron yew 山东省农业科学院 2025-04-11 CN disclosed
US-20070167452-A1 Therapeutic amide derivatives PFIZER, INC. 2007-07-19 US disclosed
US-20070167452-A1 Therapeutic amide derivatives PFIZER, INC. 2007-07-19 US disclosed
US-20070167452-A1 Therapeutic amide derivatives PFIZER, INC. 2007-07-19 US disclosed
EP-1716100-A2 THERAPEUTIC AMIDE DERIVATIVES Pfizer, Inc. (US) 2006-11-02 EP disclosed
WO-2005080317-A2 THERAPEUTIC AMIDE DERIVATIVES PFIZER JAPAN, INC. (JP) 2005-09-01 WO disclosed
WO-2005080317-A2 THERAPEUTIC AMIDE DERIVATIVES PFIZER JAPAN, INC. (JP) 2005-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167452-A1 Therapeutic amide derivatives GRIN1, GRIN2B, GRIN3A IL6ST 621/4885STAT3 1473/4885PIK3CD 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.